- Home
- PANL vs CKPT Comparison
PANL vs CKPT Comparison
Compare PANL & CKPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PANL
- CKPT
- Stock Information
- Founded
- PANL 1996
- CKPT 2014
- Country
- PANL United States
- CKPT United States
- Employees
- PANL N/A
- CKPT N/A
- Industry
- PANL Marine Transportation
- CKPT Biotechnology: Pharmaceutical Preparations
- Sector
- PANL Consumer Discretionary
- CKPT Health Care
- Exchange
- PANL Nasdaq
- CKPT Nasdaq
- Market Cap
- PANL 257.0M
- CKPT 214.4M
- IPO Year
- PANL N/A
- CKPT 2017
- Fundamental
- Price
- PANL $4.92
- CKPT $3.61
- Analyst Decision
- PANL Strong Buy
- CKPT Strong Buy
- Analyst Count
- PANL 1
- CKPT 3
- Target Price
- PANL N/A
- CKPT $10.33
- AVG Volume (30 Days)
- PANL 233.2K
- CKPT 2.4M
- Earning Date
- PANL 11-12-2024
- CKPT 11-12-2024
- Dividend Yield
- PANL 8.26%
- CKPT N/A
- EPS Growth
- PANL N/A
- CKPT N/A
- EPS
- PANL 0.47
- CKPT N/A
- Revenue
- PANL $521,238,386.00
- CKPT $47,000.00
- Revenue This Year
- PANL $8.04
- CKPT N/A
- Revenue Next Year
- PANL $13.05
- CKPT $151,162.55
- P/E Ratio
- PANL $10.24
- CKPT N/A
- Revenue Growth
- PANL 5.23
- CKPT N/A
- 52 Week Low
- PANL $4.84
- CKPT $1.38
- 52 Week High
- PANL $9.53
- CKPT $4.50
- Technical
- Relative Strength Index (RSI)
- PANL 26.60
- CKPT 41.64
- Support Level
- PANL $4.93
- CKPT $2.98
- Resistance Level
- PANL $5.29
- CKPT $4.44
- Average True Range (ATR)
- PANL 0.18
- CKPT 0.42
- MACD
- PANL -0.03
- CKPT -0.10
- Stochastic Oscillator
- PANL 7.53
- CKPT 25.66
About PANL Pangaea Logistics Solutions Ltd.
Pangaea Logistics Solutions Ltd and its subsidiaries provide seaborne drybulk transportation services. It transports drybulk cargos including grains, coal, iron, ore, pig, iron, hot briquetted iron, bauxite, alumina, cement clinker, dolomite, and limestone. The firm's services include cargo loading, cargo discharge, vessel chartering, voyage planning and technical vessel management. The company derives all of its revenues from contracts of affreightment, voyage charters and time charters.
About CKPT Checkpoint Therapeutics Inc.
Checkpoint Therapeutics Inc is an immuno-oncology biopharmaceutical company based in the USA. It focuses on the acquisition, development, and commercialization of novel, non-chemotherapy, immune-enhanced combination treatments for patients with solid tumor cancers. Its licensed portfolio of antibodies includes targeting programmed cell death-ligand 1 (PD-L1), glucocorticoid-induced TNFR-related protein (GITR) and carbonic anhydrase IX (CAIX). The company is evaluating its lead small-molecule, targeted anti-cancer agent, olafertinib, a third-generation epidermal growth factor receptor ("EGFR") inhibitor, as a potential new treatment for patients with EGFR mutation-positive non-small cell lung cancer.